Literature DB >> 7861151

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

B Dean1, K Opeskin, G Pavey, L Naylor, C Hill, N Keks, D L Copolov.   

Abstract

[3H]Paroxetine binding to particulate membrane from tissue, obtained at autopsy, from the hippocampus, frontal cortex, and caudate nucleus from subjects who had or had not had schizophrenia was measured. The density of [3H]paroxetine binding to membranes from subjects who had or had not had schizophrenia did not differ. Similarly, the affinity of [3H]paroxetine binding in the frontal cortex and caudate nucleus was not different. By contrast, the affinity of [3H]paroxetine binding to hippocampal membrane from subjects who had schizophrenia was significantly lower than the affinity of binding for the nonschizophrenic subjects (0.40 +/- 0.06 vs. 0.26 +/- 0.02; p < 0.05). As [3H]paroxetine binds to the serotonin transporter, these data suggest that the serotonin transporter is altered in the hippocampus in subjects with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861151     DOI: 10.1046/j.1471-4159.1995.64031197.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Differences between males and females in rates of serotonin synthesis in human brain.

Authors:  S Nishizawa; C Benkelfat; S N Young; M Leyton; S Mzengeza; C de Montigny; P Blier; M Diksic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia.

Authors:  B Dean; K Opeskin; G Pavey; C Hill; N Keks
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.

Authors:  N I Perrone-Bizzozero; A C Sower; E D Bird; L I Benowitz; K J Ivins; R L Neve
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.

Authors:  A Cupello; C Albano; E Gatta; S Scarrone; E Villa; G Zona
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

5.  No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus.

Authors:  L Naylor; B Dean; A Pereira; A Mackinnon; A Kouzmenko; D Copolov
Journal:  Mol Med       Date:  1998-10       Impact factor: 6.354

6.  Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.

Authors:  L Naylor; B Dean; K Opeskin; G Pavey; C Hill; N Keks; D Copolov
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders.

Authors:  J Contreras; L Hare; B Camarena; D Glahn; A Dassori; R Medina; S Contreras; M Ramirez; R Armas; R Munoz; R Mendoza; H Raventos; A Ontiveros; H Nicolini; R Palmer; M Escamilla
Journal:  Acta Psychiatr Scand       Date:  2008-11-11       Impact factor: 6.392

8.  Neural models of schizophrenia.

Authors:  S Heckers
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.